Key result
Female sex is linked to ~30% more peri-procedural complications and higher readmissions after pLAAC.
Why the study?
Gender differences in peri-procedural and readmission outcomes after percutaneous left atrial appendage closure in AF patients were not well characterized.
Does female gender increase the risk of peri-procedural complications and readmissions in patients undergoing percutaneous left atrial appendage closure?
Cohort (n=28,819)
Yes
Does female gender increase the risk of peri-procedural complications and readmissions in patients undergoing percutaneous left atrial appendage closure?
Absolute Event Rate: 8.6% vs 6.6%
p-value: p=<0.001
Women undergoing percutaneous left atrial appendage closure experience significantly higher rates of peri-procedural complications, particularly bleeding, and higher readmission rates compared to men.
Women may face higher pLAAC complications and readmissions; observational data leave open whether sex-specific strategies warrant prospective study.
Background: Thromboembolism-associated stroke is the most feared complication of Atrial fibrillation (AF). Percutaneous left atrial appendage closure (pLAAC) is indicated for stroke prevention in patients with AF who can’t tolerate long-term anticoagulation. We aim to study gender differences in peri-procedural and readmissions outcomes in pLAAC patients. Methods: Using the national readmission database from January 2016 to December 2018, AF patients undergoing the pLAAC procedure were identified. We used multivariate logistic regression analyses and time-to-event Cox regression analyses to conduct the study. Propensity matching with the Greedy method was done for the accuracy of results. Result: 28,819 patients were included in our study. Among them 11,946 (41.5%) were women and 16,873 (58.6%) were men. The mean age of overall population was 76.1 ± 8.5 years, with women ~ 1 year older than men. The overall rate of complications was higher in women (8.6% vs 6.6%, P<0.001), primarily driven by bleeding-related complications i.e., Major bleed (OR: 1.32 95% CI: 1.03-1.69, p=0.029), blood transfusion (OR: 1.45, 95% CI: 1.06-1.97, p=0.019) and cardiac tamponade (OR: 1.80, 95% CI: 1.13-2.89, p=0.014). Women had two times higher peri-procedural ischemic stroke. There was no difference in peri-procedural mortality. Women remained at 20% and 13% higher risk for readmission at 30 days and 6 months of discharge. Conclusion: Women had higher peri-procedural complications and were at higher risk of readmissions at 30 days and six months. However, there was no difference in mortality during the index hospitalization. Further studies are necessary to determine causality.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2021) conducted a cohort in Atrial fibrillation (n=28,819). Female gender vs. Male gender was evaluated on Overall rate of complications (p=<0.001). Women undergoing pLAAC had a higher overall rate of peri-procedural complications than men (8.6% vs 6.6%, P<0.001) and higher readmission risks at 30 days and 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: